Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Creative Medical Technology Holdings ( (CELZ) ).
On November 6, 2025, Creative Medical Technology Holdings‘ Compensation Committee approved bonuses for CEO Timothy Warbington and CFO Donald Dickerson. Warbington received $100,000, while Dickerson was awarded $25,000, reflecting the company’s recognition of their leadership contributions.
The most recent analyst rating on (CELZ) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on Creative Medical Technology Holdings stock, see the CELZ Stock Forecast page.
More about Creative Medical Technology Holdings
Average Trading Volume: 100,596
Technical Sentiment Signal: Sell
Current Market Cap: $8.46M
For a thorough assessment of CELZ stock, go to TipRanks’ Stock Analysis page.